Background-Transcatheter mitral valve repair (TMVR) is a treatment option in patients with symptomatic functional or degenerative mitral regurgitation (DMR) at high surgical risk. The acute effect of MitraClip procedure on mitral valve (MV) annular geometry and its relation to functional outcomes is unclear. We sought to assess immediate effect of TMVR on MV annular geometry with 3-dimensional (3D) transesophageal echocardiography and the association of MV diameter reduction with functional response after 6 months.
T ranscatheter mitral valve repair (TMVR) with the MitraClip procedure has been introduced as an alternative treatment option to surgery in high-risk patients with severe symptomatic functional mitral regurgitation (FMR) and degenerative mitral regurgitation (DMR). In recent years, MitraClip treatment has been shown effective for the reduction of mitral regurgitation (MR) severity in ≤80% of cases with an improvement of MR-related clinical symptoms. 1 Therefore, MitraClip treatment has been widely adapted for clinical use, and recent data show that it is predominantly performed in patients with functional valve disease. However, this patient cohort was under-represented in the prospective randomized Endovascular Valve Edge-to-edge Repair Study (EVERST). Therefore, a debate is ongoing about the durability of interventional edge-to-edge repair using the MitraClip in such patients because of its limited effect on the MV leaflets. 2, 3 Only limited data are available on acute changes of the MV annular geometry after MitraClip implantation. 4 We hypothesized that interventional edge-to-edge repair of MR using the MitraClip system potentially reduces MV annular diameters because of immediate and persistent tension on the MV annulus via the anterior and posterior (AP) MV leaflets. Furthermore, we aimed to assess the correlation of acute anatomic changes in MV geometry with the patients functional outcomes after follow-up.
Methods

Patients
Symptomatic patients with MR grade 3 to 4+ were evaluated for TMVR or surgery. In addition, patients with FMR and MR grade 2+ were considered for MR treatment when having an effective regurgitation orifice area of >20 mm, 2 New York Heart Association (NYHA) functional class III to IV, concomitant atrial fibrillation, and elevated pulmonary pressure, despite optimized medical and device therapy. 5 TMVR was planned after heart team decision was made that patients are not amendable for open heart surgery.
The study was approved by local ethics committee and in concordance with the Declaration of Helsinki, and all patients had to provide written informed consent before study inclusion.
Two-Dimensional and Three-Dimensional Transesophageal Echocardiography Image Acquisition
Echocardiographic assessment before, during, and after TMVR was done after current recommendations and guidelines with determination of proximal isovelocity surface area, effective regurgitation orifice area, as well as vena contracta width and regurgitant volume. 5 According to the EVERST studies, we graded severity of MR following a scale ranging between 1 and 4+. 1 Referenced to the recommendations of European Society of Cardiology, grade 1 defines mild, 2 refers to moderate, 3 stands for moderate to severe, and 4 stands for severe MR. Three-dimensional (3D) transesophageal echocardiography (TEE) was performed with a commercially available echocardiographic system (iE 33; Philips Medical Systems, Andover, MA) and a TEE probe (X7-2t) allowing acquisition of 2D and 3D TEE data sets.
Three-dimensional full volume data sets and 3D MV zoom images were acquired in all patients immediately before implantation of the MitraClip procedure and directly after Clip deployment derived from an optimized 2D intercomissural view on the MV by scanning 2D planes from 50° to 90°. MV diameters were measured off-line using a dedicated analysis software (TomTec Imaging Systems GmbH, Unterschleissheim, Germany), which enables a stepwise multiplanar approach for the delineation of the MV annulus and leaflets ( Figure 1 ). For the definition of MV annular geometry, we assessed AP diameters, lateral/medial (LM) diameters, 2D and 3D areas, MV annulus circumference, and the MV annular sphericity index (defined as AP/LM diameter). Off-line data analysis was performed by defining mitral landmarks at end diastole. After delineation of the mitral apparatus, the MV annulus was tracked automatically during the heart cycle and realigned manually when necessary. For comparison of dynamic changes of MV anatomy, we compared MV diameters at end systole and end diastole. The distance of the papillary muscles was measured in end diastole in the intercommisural view between the tips of the papillary muscles.
Procedural images were obtained by a single, experienced echocardiographer. A second echocardiographer, who was blinded to procedural outcomes and the patients characteristics, performed the off-line analysis of the 3D volume data sets. Follow-up evaluation was performed by trained study nurses, unattended by the interventionalists or procedural echocardiographer.
Definition of MR Pathogenesis
Patient cohorts were divided according to the underlying pathogenesis of MR. FMR was defined as mostly central MR with global (symmetrical) or regional (eccentric) left ventricular (LV) dilatation and reduced LV ejection fraction, despite structurally normal MV leaflets. The reasons to develop FMR are multifactorial: it is caused by pathological changes in MV annular geometry and pathological tension on the valve leaflets because of ventricular dilatation causing asymmetrical or symmetrical MV tenting and tethering. MR was determined degenerative in patients with primary pathologies of the MV leaflets and MV apparatus.
Interventional Edge-to-Edge Repair of MR and Definition of Clinical Response to TMVR
TMVR using the MitraClip system has been described in detail previously. 1 During the MitraClip procedure, severity and acute changes of MR were assessed as supposed by Foster et al 6 and Wunderlich et al. 7 We defined acute procedural success as a reduction of MR by ≥1 grade with having a residual MR of <2+. The number of clips that were implanted to reach procedural success was left to the discretion of the treating physician. Before clip release, echocardiography was performed to exclude clinical relevant MV stenosis (mean pressure gradient, >5 mm Hg). Clinical response to TMVR after follow-up was defined as a reduction in functional NYHA class of >1° (ΔNYHA>1) or an improvement of 6-minute walking distance (6MWD) of ≥21% when compared with the baseline walking distance as proposed by Reichenspurner et al. 8 We prespecified in our protocol to exclude deceased patients from statistical evaluation of clinical response to TVMR because it is unclear whether mortality rates in such high-risk patients are influenced by (unsuccessful) MitraClip procedures with nonsignificant reduction of MR volumes.
Statistical Analysis
Normal distribution of continuous variables was examined using the Kolmogorov-Smirnov test. Continuous data were expressed as mean±SD. Two-tailed P values were calculated and considered to be significant if ranging <0.05. Comparisons between FMR and DMR groups at 6 months were done using ANCOVA for continuous variables. Further comparisons were performed using Student 2-sample t test or Mann-Whitney U test, depending on the distribution of data. For categorical data, Fisher exact test or χ 2 test was calculated. Intraclass correlation coefficients for absolute agreement was used for the assessment of method agreement, with good agreement defined as >0.80. For the assessment of intraobserver variability, 20 randomly chosen patients of each group (FMR and DMR) were analyzed by the same investigator twice and by a second investigator, who was blinded to the results of the first investigator, to determine interobserver variability. Mean values and SDs between the measurements
WHAT IS KNOWN
• MitraClip procedure is an evolving technique for the treatment of patients at high surgical risk with severe degenerative mitral regurgitation.
• The durability of MitraClip therapy might be limited in patients with functional valve disease because it is limited to treatment of the mitral valve leaflets.
WHAT THE STUDY ADDS
• This study demonstrated a significant reduction of the anterior-posterior mitral valve diameter and mitral annulus area only in patients with functional mitral regurgitation, which was associated with functional outcomes after follow-up.
• The acute influence on the mitral valve geometry supports the durability of transcatheter mitral valve repair with the MitraClip in patients with functional mitral regurgitation.
• The measurable effect on the anterior-posterior diameter after clip closure might be an early indicator of patients who are likely to derive clinical benefit. were obtained, and absolute agreement among the observation was calculated using intraclass correlation coefficient analysis. Receiver operating characteristics analysis was performed to identify the predictive value of AP diameter decrease for functional response following the method of de Long. For further evaluation of predictive parameters, we performed a univariate logistic regression analysis. Statistics were performed using SPSS for Windows (PASW Statistic, version 20.0.0.0; SPSS Inc, Chicago, IL) and MedCalc statistical software version 11.4.1.0 (MedCalc Software, Mariakerke, Belgium).
Results
Baseline Data and Acute Clinical and Procedural Outcomes
From June 2010 to May 2013, 111 consecutive patients underwent TMVR with the MitraClip system at our institution, and the procedure was successfully completed in 107 patients (96%) with implantation of >1 clip in 38% of cases. Mean procedural time was 83.02±45.1 minutes (28-275 minutes) with a documented fluoroscopy time of 29.82±22.8 minutes (4-100 minutes). Four cases were unsuccessful because of unchanged MR (n=1), significant MV stenosis (acute mean pressure gradient, >12 mm Hg; n=1), and pericardial effusion (n=2).
The final study group consisted of 107 patients (age, 78±8 years) at high risk for surgical MV replacement or annuloplasty (EuroSCORE [European System for Cardiac Operative Risk Evaluation] of 30±22%; Table 1 ). When separating the study group according to the pathogenesis of MR, 71 (66%) patients were diagnosed with FMR and 36 (34%) patients with DMR.
Patients with FMR had a significantly lower LV ejection fraction (38±14% and 58±14%; P<0.0001), they did more often experience hyperlipidemia (P=0.02) and diabetes mellitus (P=0.003) and were more often smokers (P=0.04). Patients with DMR were significantly older than patients with FMR (83±7 and 76±8 years; P<0.001; Table 1 ). 
Echocardiographic Measures After Follow-Up
Echocardiography revealed sustained reduction of MR <2+ in 95% of patients with FMR and 94% of subjects with DMR. After 6 months of follow-up, we found a significant reduction in estimated systolic pulmonary arterial pressures (46±15 and 39±17 mm Hg; P=0.02) in the overall cohort, predominantly caused by the reduction of systolic pulmonary arterial pressure in patients with FMR (46±15 and 37±14 mm Hg; P=0.009) but not in subjects with DMR. LV volumes (endsystolic volume/end-diastolic volume) and ejection fraction improved slightly in both groups without reaching statistical significance after 6 months ( Table 2) .
With regard to other geometric parameters (eg, regurgitant volume, papillary muscle distance, and LV volume or diameter), we observed no changes directly after clip implantation in both groups ( Table 2 ). Mean MV pressure gradients increased significantly in both groups after the procedure (FMR, P<0.001; DMR, P=0.007; Table 2 ). In 1 patient with DMR, a residual mean gradient of 7.4 mm Hg after clip deployment was tolerated based on an individual decision. The patient experienced severe MR (grade 4) and TMVR was the only possible treatment in this case.
Clinical Measures After Follow-Up
We found a significant improvement of functional NYHA class (FMR, P<0.001; DMR, P<0.001) and 6MWD (FMR, 214±105 and 308±124 m; P<0.001 and DMR, 223±147 and 317±129 m; P=0.01) in both groups. Measured levels of N-terminal probrain natriuretic peptide were significantly reduced only in patients with FMR (7211±13 751 and 2458±2713 pg/mL; P=0.04; Table 2 ; Table IIA and IIB in the Data Supplement). Of the patients who were nonresponders following our definition, 8 (73%) did not improve in NYHA functional class, 5 (45%) failed to show improvement in 6MWD, and 4 (36%) showed no improvement in both variables (NYHA and 6MWD). When comparing the groups about baseline characteristics, we found significant differences in sex (P=0.03) and posterior mitral leaflet length (P=0.03; Table 3 ).
Three-Dimensional Assessment of MV Annular Geometry Before and After TMVR
We found no statistically significant differences between groups at baseline about MV annular geometry-defining measures ( Table 2) . When analyzing MV diameters, area, and circumference immediately after clip deployment, only patients with FMR experienced significant reductions of the MV AP diameters Table IIA and IIB in the Data Supplement). Changes of MV diameters were independent from the number of implanted clips (P=0.42). When comparing end-systolic and end-diastolic MV geometry-defining measures, we found significant changes of the MV geometry and only the AP diameter was fixed during the heart cycle after clip deployment, indicating on a constrained influence of the clip on the AP portion of the mitral annulus (Table 4) .
In contrast to the FMR group, all measures on MV annular geometry were unchanged in patients with DMR after TMVR ( Table 2 ; Figures 3 and 4) .
The findings from 3D TEE on MV annular dimensions had a good reproducibility as shown by absolute intra-and interclass agreement with all correlation coefficients ranging >0.8 ( Table III in 
Preliminary Findings on AP Diameter-Related Clinical Response to TMVR
After follow-up, 88% of patients (n=72; 44 [61%] FMR; 28 [39%] DMR) were found to be clinical responders to TMVR. When comparing the patient groups according to the pathogenesis of MR, the AP diameter was significantly more reduced in patients with FMR responding to TMVR when compared with that in nonresponders. In patients with DMR, the amount of AP diameter reduction was apparently not related to a favorable clinical response, as defined in this study, but there were only 4 nonresponders in the DMR cohort, which is too few to draw any conclusions ( Figure 5 ).
After statistical evaluation, the amount of acute reduction of the AP diameter was associated with clinical response to TMVR (area under the curve, 0.81; 95% confidence interval, 0.64-0.97; P=0.002) with a cutoff value of ≥6.4% for AP reduction having a specificity of 82% (95% confidence interval, 48.2-97.7) and sensitivity of 82% (95% confidence interval, 60.3-84.5) for the prediction of clinical response. This association was confirmed by additional univariate regression analysis ( Table 5 ).
Discussion
To the best of our knowledge, this is the first study to analyze acute changes in MV annular geometry interventional edge-to-edge repair of MR with the MitraClip system using a dedicated 3D MV analysis software. The main findings of our study are as follows:
1. Interventional edge-to-edge repair of MR using the MitraClip system has an acute effect on MV annular geometry in patients with FMR. 2. The amount of acute AP diameter reduction was associated with clinical response to TMVR on univariable analysis after 6 months. Therefore, this parameter might be an early indicator of patients who are likely to derive clinical benefit. 
Patient Selection and Definition of Successful TMVR With the MitraClip System
Anatomic factors predicting patients eligibility for the Mitra-Clip procedure have been defined in the EVERST study, which was mainly focused on subjects with degenerative valve disease. 9 The clinical value of these measures has not been proven in prospective studies yet. Furthermore, the predictive value of these measures is questionable because in clinical practice mainly patients with FMR at high surgical risk undergo Mitra-Clip procedures, which were not investigated rigorously. 4, 10 Nevertheless, clinical success rates of MitraClip procedures are consistently reported to be high, ranging between 75% and 95%, [11] [12] [13] and real-time 3D TEE has been established as an indispensable tool for patient selection, procedural guidance, and the evaluation of acute interventional success. 14 However, acute interventional goals predicting durable device-success are not well defined. Simple color Dopplerbased evaluation of the severity of MR during TMVR is limited because of the fact that TMVR is performed under general anesthesia, and color Doppler flow estimation of MR with the proximal isovelocity surface area method might be inappropriate after edge-to-edge repair. 7, 15 Furthermore, the clip itself produces acoustic shadows that obscure the area of proximal convergence and thus conflicts accurate determination of the proximal isovelocity surface area in a relevant subset of cases. 7 Therefore, it seems important to identify independent anatomic implantation goals predicting sustained procedural success. As recently shown by Grayburn et al, 16 MR treatment with the MitraClip is associated with positive LV remodeling during 12 months, associated to the amount of MR reduction. Patients with DMR experienced improvement only in LV end-diastolic volume, and patients with FMR also in LV endsystolic volume. In the presented results, we found no effect of the procedure on LV remodeling, which might be because of the fact that follow-up period was significantly shorter. Another possible explanation might be that significant LV remodeling was not observed because the actual reduction in regurgitant volume was smaller or because the severity of MR was less at baseline in the described series.
Anatomic Changes of MV Annular Geometry After MitraClip Implantation
Only a few studies examined the acute effect of MitraClip treatment on the MV anatomy using 3D TEE. Altiok et al 17 studied 39 patients with FMR (effective regurgitation orifice area, 0.3±0.2 cm 2 ) at high surgical risk. They found left atrial and LV end-diastolic volume significantly more reduced after follow-up in patients with an acute reduction of the measured 3D vena contracta width by >50% (P=0.005). This group did not correlate their findings with clinical outcome measures, and changes in MV anatomy were not described.
In a recently published retrospective analysis of 55 patients, Schmidt et al 14 found relevant reductions of the measured MV AP diameters in a subset of 41 patients with FMR (mean AP reduction, 0.28±0.32 cm; P<0.001) and not in 14 patients with DMR, which is in line with our results, but the authors did not correlate these echocardiographic findings with clinical outcome measures after MitraClip treatment.
Of note, we found evidence for dynamic changes (systolic-diastolic) in annulus geometry after clip placement. Interestingly, the end-systolic MV areas were larger post-than preclip implantation. These findings, although not related to clinical response, might be of interest for future studies determining the effects of interventional edge-to-to-edge repair on mitral annular geometry.
Influence of AP Diameter Reduction on Procedural Success of TMVR
Up to now, effective MitraClip treatment has been predominantly defined by the amount of acute MR reduction during the procedure, and values predicting favorable patient outcomes after follow-up have not been investigated to date. Of note, recent studies described a significant relapse of moderate-to-severe MR, despite good intraprocedural MR reduction in ≤20% of patients, which was not related to immediate or late clip detachment. 18, 19 The presented results confirm the fact that TMVR with the MitraClip system acutely influences the MV annular anatomy in patients with FMR. After assessment of dynamic changes on MV geometry, only the AP diameter remained unchanged or stable during the heart cycle after clip implantation, suggesting a constrained influence of the clip on the mitral annulus. Furthermore, we found the amount AP diameter reduction to be associated with the patients clinical response to TMVR after follow-up and, therefore, this variable might be an indicator of effective MitraClip therapy. In context with the cited studies, there is growing evidence for a significant effect of the MitraClip procedure on the MV annular geometry. These findings support the short-term durability of TMVR with the MitraClip, despite its effect limited on the MV leaflets for the treatment of FMR. 2, [20] [21] [22] Of note, other anatomic factors defining LV or MV dimensions were not different between the groups, except for the posterior mitral leaflet length. As suggested by the EVERST investigators, 1 the MV leaflet length seems important to enable appropriate leaflet grasping, which is confirmed by our findings.
Limitations
Our study is limited by its single side character and limited patient number; the presented results, therefore, are preliminary and must be reconfirmed in independent patient cohorts. The small number of nonresponders, particularly in the DMR group, limits the ability of the study to make inferences about associations between geometric changes and clinical outcomes. A single experienced echocardiographer performed all intraprocedural echocardiographic images, and the data have not been validated by an independent echocardiographic core laboratory or other imaging modalities. We acknowledge a possible bias because of an incomplete clinical follow-up rate at 6 months of 78%. Furthermore, simple comparison of ΔAP diameter might neglect baseline diameter, as a possible important modifier of treatment results. Because the group sizes are modest, our results should not be overemphasized, especially about differences with P>0.01; using α=0.05 for each test may have inflated type I error.
Conclusions
Three-dimensional TEE enables the assessment of acute changes of the MV annular geometry in patients undergoing interventional edge-to-edge-repair with the MitraClip system.
Only patients with functional MR experienced a significant reduction of MV annular dimensions, which was associated with clinical response to TMVR. These findings, indicating on a clinically relevant effect of interventional-edge-to-edge repair on the MV geometry, should be confirmed with further studies. No. of clips -0.5 1.0 0.9 0.8-1.0 0.61 AP indicates anteriorposterior; CI, confidence interval; CRF, chronic renal failure; COV, cutoff value; EROA, effective regurgitation orifice area; EuroSCORE, European System for Cardiac Operative Risk Evaluation; LVEF, left ventricular ejection fraction; NT proBNP, Nterminal pro-brain natriuretic peptide; PISA, proximal isovolumetric surface area; sPAP, systolic pulmonary arterial pressure; and V. contracta, vena contracta width.
